Veterinary practice owners typically sell once. That means one opportunity to pick the right advisor, run the right process, and reach the right buyers. The consolidation wave that has reshaped veterinary medicine over the past decade has created a bifurcated market: individual associate buyers using SBA financing on one side, and PE-backed consolidators with formal acquisition programs on the other. The same $800,000-revenue general practice might close at $640,000 under a traditional broker process and $2.4 million through a well-run consolidator auction. That gap is the advisor choice.
The veterinary consolidator market has grown substantially, with national and regional platforms running active acquisition pipelines across general practices, specialty hospitals, and emergency centers. These buyers run structured diligence processes, use standardized quality-of-earnings templates, and negotiate deal terms that include rollover equity, employment agreements, and earnouts that a vet practice broker has rarely encountered. Getting the best outcome from that buyer pool requires an advisor who has been through their process before.
This guide covers the advisors that do both types of veterinary practice transactions well, with clear guidance on which type fits your situation.
Why Veterinary M&A Is Different From General Business Sales
Veterinary practices have transaction-specific complexities that catch generalist advisors off guard. An advisor who has run veterinary consolidator transactions knows how to preempt these; one who hasn't will surface them as surprises in diligence, where they become leverage points for price reductions.
- Production-based compensation normalization. This is the most commonly misapplied adjustment in veterinary practice valuations. Owner-veterinarian compensation typically runs at 18 to 22% of production, but the buyer will staff a replacement veterinarian at a similar production cost. When you normalize for owner compensation, you can't add back the full owner salary and then expect a buyer to staff a replacement for free. The correct adjustment accounts for the replacement production cost at market rates. Advisors who've done vet transactions know this. Generalists routinely over-normalize and then lose the credit in diligence when the buyer's quality-of-earnings team catches it.
- DEA Schedule II-V controlled substances. Veterinary practices dispense ketamine, opioids, and other controlled substances under a DEA registration issued to the practice entity. Like dental, this registration doesn't transfer automatically. The incoming owner must apply for their own DEA registration at the practice address, which takes 4 to 12 weeks. Practices with active inpatient surgical programs or emergency services need DEA transition planning built into the deal structure from day one.
- Real estate treatment. Whether the selling veterinarian owns the building matters enormously to the transaction structure. Real estate is almost always sold separately from the practice or structured as a sale-leaseback, creating two simultaneous closings with different buyer pools. The lease terms negotiated at close will be scrutinized by the practice buyer because lease cost is a significant EBITDA driver. Advisors who have run vet consolidator deals know how to structure favorable lease terms that don't create future EBITDA headwinds.
- Multi-doctor dependency risk. Buyers apply a risk discount when a disproportionate share of revenue is attributable to the selling veterinarian's client relationships. Practices where the owner sees 60% or more of the patient volume face harder negotiations on price and often on earnout structure. An advisor who has navigated this before knows how to pre-position the dependency risk in the information memorandum rather than letting buyers discover it in diligence.
- Buyer universe segmentation. General practice, specialty, and emergency veterinary hospitals attract different buyer pools with different valuation models and acquisition criteria. A general practice buyer and a specialty hospital buyer are not interchangeable. Running a process that targets the wrong buyer type wastes months and poisons your best-case outcome. The advisor's buyer list is where the process outcome is determined, and vet M&A experience is what makes the buyer list accurate.
($300K+ adjusted EBITDA)
(lower entry barriers to consolidator buyers)
(advisor engagement to funded close)
For a broader look at how healthcare service businesses are valued, the healthcare M&A advisors guide covers the full spectrum from physician practices to specialty hospital platforms.
Which Type of Advisor Fits Your Practice
Before contacting any advisor, you need to know which category of advisor is the right match. A vet practice broker running an individual-buyer process and a healthcare M&A boutique running a consolidator auction are not interchangeable services. The wrong choice means a worse outcome.
| Practice Profile | Target Buyer Type | Advisor Category | Typical Valuation Framework |
|---|---|---|---|
| Solo/2-doctor GP, <$2M enterprise value | Associate vet (SBA financed) | Vet transition specialist | 1.0–1.4x revenue |
| Multi-doctor GP, $300K–$1M adjusted EBITDA | Regional consolidators, some PE | Vet M&A specialist or healthcare boutique | 5–8x EBITDA |
| Specialty or emergency hospital, any size | Specialty consolidators, PE platforms | Healthcare M&A boutique with vet experience | 8–12x EBITDA |
| Multi-location veterinary group ($1M+ EBITDA) | National consolidators, healthcare PE | Healthcare investment bank | 8–12x in competitive process |
The inflection point that matters most is around $300,000 to $500,000 in adjusted EBITDA after production-based compensation normalization. Below that threshold, individual associate buyers are your primary market. Above it, you're in consolidator territory. Run the practice valuation calculator to get an initial range before approaching advisors.
Best M&A Advisors for Veterinary Practice Sales
The seven advisors below cover both segments of the veterinary M&A market. We've organized them starting with healthcare M&A boutiques that run institutional consolidator processes, then moving to veterinary-specific transition advisors for individual-buyer transactions.
1 Provident Healthcare Partners
Provident Healthcare Partners is a healthcare-focused investment bank with an explicit practice in veterinary M&A alongside physician groups, dental platforms, and ambulatory services. The firm concentrates on the lower middle market of healthcare services, which includes the growing tier of multi-doctor and multi-location veterinary practices that have crossed the consolidator-eligible threshold. Provident's advisors have run sell-side processes specifically for veterinary group platforms targeting PE-backed consolidators and national veterinary groups, and their buyer relationships in the veterinary consolidation space are current and active.
For veterinary sellers targeting institutional buyers, Provident brings a healthcare M&A process that no generalist advisor can replicate: a formal information memorandum structured for consolidator diligence teams, active relationships with the PE platforms and strategic acquirers most likely to bid competitively for your practice type, and transaction experience that covers production-based compensation normalization, DEA planning, and real estate structuring. Their lower-middle-market focus means they're accessible to practices that wouldn't qualify for a larger healthcare bank's attention. Sellers with $3M to $25M in enterprise value who want the discipline of a structured competitive process should have Provident on their short list.
2 Houlihan Lokey (Healthcare Group)
Houlihan Lokey's Healthcare Group is one of the most active healthcare M&A practices in the middle market globally, and the team's coverage explicitly includes veterinary alongside physician groups, dental platforms, behavioral health, and other healthcare service businesses. For veterinary groups above $1 million in EBITDA or large multi-location platforms in the $10 million to $100 million enterprise value range, Houlihan Lokey's scale and PE sponsor relationships are genuinely competitive with any advisory firm in the market.
The firm's particular strength is its relationships with healthcare-focused private equity sponsors. Most large veterinary consolidator transactions involve PE-backed buyers, and Houlihan Lokey's institutional relationships with those sponsors create competitive auction dynamics that smaller boutiques can't replicate. If your veterinary group is large enough to attract national consolidator platforms and institutional PE buyers, Houlihan Lokey's healthcare team belongs in your advisor evaluation. They're not the right fit for solo practices or small multi-doctor practices below the consolidator acquisition threshold.
3 Harris Williams (Healthcare Services)
Harris Williams has a dedicated healthcare services practice that covers veterinary alongside behavioral health, dental, and other healthcare service platforms at the middle market level. The firm's strength is PE sell-side transactions: running competitive auction processes for PE-backed healthcare businesses seeking to sell to strategic acquirers or other financial sponsors. For veterinary group platforms that already have a PE sponsor and are running a secondary process or seeking a strategic buyer, Harris Williams' sponsor relationships and healthcare services track record make them a consistent top-tier option.
Harris Williams is most relevant for larger veterinary transactions where the business has a PE sponsor, multiple locations, and an operations team that can run the practice without the founding veterinarian. The firm runs the institutional sale process that PE-backed platforms require: a quality of earnings package, formal information memorandum, and controlled auction that creates the buyer competition driving the best outcomes. For owner-operated practices without PE backing, the firm's process economics typically aren't a fit.
4 Lincoln International (Healthcare)
Lincoln International's healthcare practice covers veterinary and physician group transactions at the $25 million to $300 million enterprise value range. Lincoln is employee-owned, which creates retention of senior healthcare banking talent and genuine partner involvement in client transactions. The firm's healthcare team has closed veterinary transactions involving multi-location groups, specialty hospital platforms, and consolidator add-on deals, and maintains buyer relationships across the national veterinary consolidator and PE-backed veterinary platform communities to run a credible competitive process at that size level.
Lincoln fits veterinary sellers who've built a multi-location group with meaningful EBITDA and want the full institutional sell-side process with a firm that has actual healthcare M&A track record. The firm's global network is relevant for large veterinary platform sales that might attract international strategic buyers, a consideration that has grown more relevant as global veterinary consolidators have become active in the U.S. market.
5 Capstone Partners (Healthcare)
Capstone Partners is a national mid-market investment bank with a healthcare and life sciences practice that serves veterinary and other healthcare service businesses in the $5 million to $75 million enterprise value range. The firm operates across the full mid-market and offers an accessible entry point for practices that have crossed the consolidator-eligible threshold but don't yet have the scale to attract the largest healthcare boutiques. Capstone's healthcare team covers veterinary practice transactions alongside dental, behavioral health, and other provider-based services businesses.
For veterinary sellers in the $5 million to $30 million enterprise value range who want a structured sell-side process with institutional buyer outreach but find that larger healthcare boutiques have minimum deal sizes above their practice value, Capstone provides a practical middle path. The firm's national presence and mid-market buyer relationships allow it to run a credible competitive process at deal sizes that fall below the threshold of the largest healthcare banks but above what vet transition specialists handle. This is a meaningful gap in the market, and Capstone fills it across healthcare service sub-sectors including veterinary.
6 Simmons & Associates Veterinary Practice Advisors
Simmons & Associates is the dominant national veterinary practice transition advisory firm for the individual-buyer segment of the market, with regional advisors operating across the United States since 1987. The firm focuses on solo and small multi-doctor practices selling to incoming veterinarians, handling practice valuation, buyer sourcing, due diligence coordination, and transaction management for practices that don't require an institutional sell-side process. Simmons advisors understand SBA financing timelines, know the veterinary board licensing and DEA steps that individual-buyer transactions require, and bring networks of veterinarians actively seeking to purchase practices in specific markets.
For veterinary practice owners with adjusted EBITDA below $300,000 and a solo or two-doctor practice, Simmons-type specialists are the appropriate advisor category. They work on commission structures aligned with sale price rather than monthly retainers, which fits the economics of smaller transactions. The tradeoff is that these advisors don't reach PE-backed or national consolidator buyers, which means if your practice profile has crossed into consolidator-eligible territory, you should be speaking to a healthcare boutique, not a transition specialist. Simmons publishes regular veterinary market data including practice valuation benchmarks that are worth reviewing regardless of which advisor you ultimately use.
7 Professional Transition Strategies (PTS)
Professional Transition Strategies is a veterinary and dental practice transition advisory firm serving the individual-buyer segment across both specialties. PTS advisors work with practice owners preparing to sell to an associate or a local buyer group, handling valuation, buyer-seller matching, and transaction coordination for practices in the individual-buyer transaction tier. The firm operates nationally with regional advisors covering veterinary practice markets across the U.S.
PTS serves the same function as Simmons & Associates in the individual-buyer veterinary practice market. When comparing vet transition advisors in this tier, the relevant questions are the same: Does the advisor have active buyer relationships in your specific geographic market? Do they have closed transactions in your practice type and size range? Can they provide recent references from selling veterinarians? The quality of individual advisors within these firms varies significantly by region, so firm brand matters less than the specific advisor's local track record. For practices that have crossed the consolidator-eligible threshold, both PTS and Simmons will likely refer you back to a healthcare M&A boutique rather than try to run a process they're not built for.
How to Evaluate a Veterinary M&A Advisor
The questions below will surface what matters faster than any amount of marketing material review. Ask them directly in the first conversation.
- How many veterinary transactions have you closed in the last two years, and can you share anonymized deal details? Transaction track record in your specific practice type and size range is the most direct evidence of relevant capability. An advisor who can't point to three or more closed veterinary transactions in the last 24 months is learning on your deal.
- Which consolidator platforms are actively acquiring in my market, and which ones fit my practice type? Advisors who are current in the veterinary M&A market know the acquisition appetite of specific platforms, what practice types each consolidator is targeting, and which ones have capital deployed and which are paused. An advisor who knows this tells you which buyers to prioritize. One who doesn't know can't answer the question.
- How do you handle production-based compensation normalization, and what does adjusted EBITDA look like for a practice with my owner compensation structure? This question separates advisors who have run veterinary transactions from those who haven't. An advisor with real vet experience will explain the replacement production cost framework immediately. One without it will give you a generic "add back owner salary" answer that won't hold up in a quality-of-earnings review.
- Who specifically will run my deal from kick-off through close? At larger advisory firms, the managing director who pitches you and the analyst who manages your data room are different people. Confirm which senior advisor stays on the deal from start to finish, and ask for their specific involvement in prior veterinary transactions, not their firm's general healthcare track record.
- What are your fee terms, and how is the retainer credited at close? For healthcare boutiques, ask whether the monthly retainer is fully or partially credited against the success fee at closing. Many firms credit 50 to 100% of retainer paid. Knowing this prevents surprises and lets you compare total cost across firms on an apples-to-apples basis.
One question that screens advisors quickly: ask for the three consolidator platforms most likely to acquire your specific practice type in your market right now, and what each is paying in multiples. A current veterinary M&A advisor answers specifically. One who isn't active in the market gives a generic non-answer about "multiple interested parties."
Match With a Veterinary-Experienced M&A Advisor
ProCloser matches veterinary practice owners with M&A advisory firms that have verified veterinary and healthcare M&A track records. Tell us about your practice and we'll find the right fit. Free to sellers, confidential.
Get Matched With a Vet M&A Advisor →For a broader view of healthcare practice valuations across dental, veterinary, and physician group transactions, the M&A advisors for dental practices guide covers the parallel DSO acquisition market and the same institutional process considerations that apply to veterinary consolidator sales.